Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model.

Saoulidis S, Simitsopoulou M, Dalakiouridou M, Walsh TJ, Wheat LJ, Papaioannidou P, Roilides E.

Mycoses. 2011 Sep;54(5):e486-92. doi: 10.1111/j.1439-0507.2010.01958.x. Epub 2010 Oct 29.


Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus.

Dotis J, Simitsopoulou M, Dalakiouridou M, Konstantinou T, Panteliadis C, Walsh TJ, Roilides E.

J Antimicrob Chemother. 2008 Apr;61(4):810-7. doi: 10.1093/jac/dkn036. Epub 2008 Feb 13.


Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.

Katragkou A, Chatzimoschou A, Simitsopoulou M, Dalakiouridou M, Diza-Mataftsi E, Tsantali C, Roilides E.

Antimicrob Agents Chemother. 2008 Jan;52(1):357-60. Epub 2007 Oct 15.


Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus.

Dotis J, Simitsopoulou M, Dalakiouridou M, Konstantinou T, Taparkou A, Kanakoudi-Tsakalidou F, Walsh TJ, Roilides E.

Antimicrob Agents Chemother. 2006 Mar;50(3):868-73.


Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B.

Simitsopoulou M, Roilides E, Dotis J, Dalakiouridou M, Dudkova F, Andreadou E, Walsh TJ.

Antimicrob Agents Chemother. 2005 Apr;49(4):1397-403.


Supplemental Content

Loading ...
Support Center